Cargando…
Challenging the pipeline
This commentary presents a thought experiment seeking to answer the key question: “If you were to put aside all the traditional drug discovery processes and start a new drug discovery program that places the highest priority on human and disease-relevant models throughout the entire process, how cou...
Autores principales: | Loskill, Peter, Hardwick, Rhiannon N., Roth, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452595/ https://www.ncbi.nlm.nih.gov/pubmed/34525380 http://dx.doi.org/10.1016/j.stemcr.2021.08.004 |
Ejemplares similares
-
How full is our antihypertensives pipeline?
por: Gude, Dilip
Publicado: (2012) -
How should we address the pipeline problem?
por: Braun, Hillary J.
Publicado: (2016) -
Dry antibiotic pipeline: Regulatory bottlenecks and regulatory reforms
por: Gupta, Sandeep Kumar, et al.
Publicado: (2014) -
The leaky pipeline of publications and knowledge generation in medical education
por: Kusurkar, Rashmi A.
Publicado: (2022) -
Payment in challenge studies from an economics perspective
por: Ambuehl, Sandro, et al.
Publicado: (2020)